A REPORT ON ANTIMENINGITIS VACCINATION AND OBSERVATIONS ON AGGLUTININS IN THE BLOOD OF CHRONIC MENINGOCOCCUS CARRIERS

F L Gates1

  • 1Base Hospital, Fort Riley, Kansas, and The Rockefeller Institute for Medical Research, New York.

Insights

A meningococcus vaccine was administered to volunteers, demonstrating the presence of specific antibodies in vaccinated individuals and chronic carriers. This suggests antibodies may confer immunity against epidemic meningitis.

Area of Science:

  • Immunology
  • Vaccinology
  • Epidemiology

Background:

  • Meningococcal infections pose a significant public health threat.
  • Understanding the immune response to meningococcus is crucial for developing effective prevention strategies.

Purpose of the Study:

  • To evaluate the safety and immunogenicity of a meningococcus vaccine.
  • To investigate the presence of specific antibodies in vaccinated individuals and chronic carriers.

Main Methods:

  • Subcutaneous administration of a meningococcus vaccine to approximately 3,700 volunteers over three weekly intervals.
  • Monitoring for local and general reactions post-vaccination.
  • Serological analysis to detect specific meningococcus agglutinins in blood serum.

Main Results:

  • Vaccination with meningococcus vaccine generally resulted in mild reactions.
  • Specific meningococcus agglutinins were detected in the blood serum of vaccinated individuals.
  • Agglutinins were also identified in the blood serum of chronic meningococcus carriers.

Conclusions:

  • The meningococcus vaccine is generally well-tolerated.
  • Vaccination induces a specific immune response, evidenced by agglutinin production.
  • The presence of specific antibodies in chronic carriers may explain their relative immunity to epidemic meningitis.

Related Concept Videos

Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...